Advertisement

Sumatriptan Nasal Spray

[26 August 2016]

Products Affected - Description

Imitrex nasal spray, GlaxoSmithKline
20 mg/actuation, inhaler, 6 count (NDC 00173-0523-00)

Reason for the Shortage

  • GlaxoSmithKline could not provide a reason for the shortage.
  • Sandoz has sumatriptan nasal spray on shortage due to product constraints.

Available Products

Imitrex nasal spray, GlaxoSmithKline
5 mg/actuation, inhaler, 6 count (NDC 00173-0524-00)
 
Sumatriptan nasal spray, Sandoz
5 mg/actuation, inhaler, 6 count (NDC 00178-6524-86)
20 mg/actuation, inhaler, 6 count (NDC 00178-6523-86)

Estimated Resupply Dates

GlaxoSmithKline has sumatriptan 20 mg nasal spray on back order and the company estimates a release date of early-September 2016.

Related Shortages

Updated

August 26, 16 and 1, June 16 and 9, May 24 and 12, March 15 and 2, January 12, 2016; December 16, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing